These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 37991685)

  • 1. Fighting to Breathe and Fighting for Health-Related Quality of Life: Measuring the Impact of Being Dependent on Technology for Breathing on the Child and Their Caregiver.
    Verstraete J; Booth C; Booth J; Peer S; McGuire J; Kritzinger F; Gray T; Zibi N; Shabangu P; Zampoli M
    Patient; 2024 Jan; 17(1):65-82. PubMed ID: 37991685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparing the Psychometric Performance of Generic Paediatric Health-Related Quality of Life Instruments in Children and Adolescents with ADHD, Anxiety and/or Depression.
    O'Loughlin R; Jones R; Chen G; Mulhern B; Hiscock H; Devlin N; Dalziel K;
    Pharmacoeconomics; 2024 Jun; 42(Suppl 1):57-77. PubMed ID: 38329689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative Psychometric Performance of Common Generic Paediatric Health-Related Quality of Life Instrument Descriptive Systems: Results from the Australian Paediatric Multi-Instrument Comparison Study.
    Jones R; O'Loughlin R; Xiong X; Bahrampour M; Devlin N; Hiscock H; Chen G; Mulhern B; Dalziel K;
    Pharmacoeconomics; 2024 Jun; 42(Suppl 1):39-55. PubMed ID: 37955799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EQ-5D-Y-3L and EQ-5D-Y-5L proxy report: psychometric performance and agreement with self-report.
    Fitriana TS; Purba FD; Stolk E; Busschbach JJV
    Health Qual Life Outcomes; 2022 Jun; 20(1):88. PubMed ID: 35659313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient-caregiver agreement and test-retest reliability of the EQ-5D-Y-3L and EQ-5D-Y-5L in paediatric patients with haematological malignancies.
    Zhou W; Shen A; Yang Z; Wang P; Wu B; Herdman M; Luo N
    Eur J Health Econ; 2021 Sep; 22(7):1103-1113. PubMed ID: 33950465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychometric Performance Comparison of the Adapted versus Original Versions of the EQ-5D-Y-3L and -Y-5L in Proxy Respondents for 2- to 4-Year-Olds.
    van Heusden A; Rivero-Arias O; Herdman M; Hiscock H; Devlin N; Dalziel K;
    Pharmacoeconomics; 2024 Jun; 42(Suppl 1):129-145. PubMed ID: 38238604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychometric validation of the Chinese versions of EQ-5D-Y-3L and the experimental EQ-TIPS in children and adolescents with COVID-19.
    Zhou W; Li Y; Busschbach J; Herdman M; Yang Z; Lu Y
    Eur J Health Econ; 2024 Jul; ():. PubMed ID: 39066840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validity and responsiveness of EQ-5D-Y in children with haematological malignancies and their caregivers.
    Zhou W; Shen A; Yang Z; Wang P; Wu B; Herdman M; Busschbach J; Luo N
    Eur J Health Econ; 2024 Nov; 25(8):1361-1370. PubMed ID: 38356007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measurement properties and responsiveness of the EQ-5D-Y-5L compared to the EQ-5D-Y-3L in children and adolescents receiving acute orthopaedic care.
    Verstraete J; Marthinus Z; Dix-Peek S; Scott D
    Health Qual Life Outcomes; 2022 Feb; 20(1):28. PubMed ID: 35177084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychometric performance of the Chichewa versions of the EQ-5D-Y-3L and EQ-5D-Y-5L among healthy and sick children and adolescents in Malawi.
    Ngwira LG; Maheswaran H; Verstraete J; Petrou S; Niessen L; Smith SC
    J Patient Rep Outcomes; 2023 Mar; 7(1):22. PubMed ID: 36892714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigating the psychometric properties of the EQ-5D-Y-3L, EQ-5D-Y-5L, CHU-9D, and PedsQL in children and adolescents with osteogenesis imperfecta.
    Xu RH; Zhu L; Sun R; Tan RL; Luo N; Zou S; Dong D
    Eur J Pediatr; 2022 Dec; 181(12):4049-4058. PubMed ID: 36156120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How does the EQ-5D-Y Proxy version 1 perform in 3, 4 and 5-year-old children?
    Verstraete J; Lloyd A; Scott D; Jelsma J
    Health Qual Life Outcomes; 2020 May; 18(1):149. PubMed ID: 32448278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the EQ-5D-Y-5L, EQ-5D-Y-3L and PedsQL in children and adolescents.
    Verstraete J; Scott D
    J Patient Rep Outcomes; 2022 Jun; 6(1):67. PubMed ID: 35708825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Comparison of the Psychometric Properties of the EQ-5D-Y-3L and EQ-5D-Y-5L Using Paediatric Multi-Instrument Comparison (P-MIC) Study Data.
    Bahrampour M; Devlin N; Jones R; Dalziel K; Mulhern B;
    Pharmacoeconomics; 2024 Jun; 42(Suppl 1):95-111. PubMed ID: 38748193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of the child's perceived general health on the primary caregiver's health status.
    Verstraete J; Ramma L; Jelsma J
    Health Qual Life Outcomes; 2018 Jan; 16(1):8. PubMed ID: 29321017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychometric Properties of the EQ-5D-Y-5L for Children With Intellectual Disability.
    Downs J; Norman R; Mulhern B; Jacoby P; Reddihough D; Choong CS; Finlay-Jones A; Blackmore AM
    Value Health; 2024 Jun; 27(6):776-783. PubMed ID: 38467188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Testing measurement properties of two EQ-5D youth versions and KIDSCREEN-10 in China.
    Pei W; Yue S; Zhi-Hao Y; Ruo-Yu Z; Bin W; Nan L
    Eur J Health Econ; 2021 Sep; 22(7):1083-1093. PubMed ID: 33893889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparing measurement properties of EQ-5D-Y-3L and EQ-5D-Y-5L in paediatric patients.
    Fitriana TS; Purba FD; Rahmatika R; Muhaimin R; Sari NM; Bonsel G; Stolk E; Busschbach JJV
    Health Qual Life Outcomes; 2021 Nov; 19(1):256. PubMed ID: 34781978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The validity and reliability of the interviewer-administered EQ-5D-Y-3L version in young children.
    Amien R; Scott D; Verstraete J
    Health Qual Life Outcomes; 2023 Feb; 21(1):19. PubMed ID: 36814254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychometric performance of proxy-reported EQ-5D youth version 5-level (EQ-5D-Y-5L) in comparison with three-level (EQ-5D-Y-3L) in children and adolescents with scoliosis.
    Lin J; Wong CKH; Cheung JPY; Cheung PWH; Luo N
    Eur J Health Econ; 2022 Nov; 23(8):1383-1395. PubMed ID: 35122171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.